Please login to the form below

Not currently logged in
Email:
Password:

licencing

This page shows the latest licencing news and features for those working in and with pharma, biotech and healthcare.

Chiesi's ultra-rare genetic disorder therapy wins European backing

Chiesi's ultra-rare genetic disorder therapy wins European backing

Europe.”. Lamzede, which has been investigated in 33 patients, both adults and children, and the Italian group expects a licencing decision by the European Commission in the second quarter of 2018.

Latest news

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Akari Therapeutics strengthens board Akari Therapeutics strengthens board

    Grissinger (pictured right) has spent 22 years at Johnson &Johnson, holding positions of vice president and head of worldwide pharmaceutical licencing, as well as vice president and head of worldwide pharmaceutical

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics